Peripheral painful neuropathy was induced in mice by the administration of vincristine sulfate, according to the previously reported method [2,28]. Briefly, vincristine sulfate (75 μg kg, i.p.) was administered intraperitoneally once-daily for 10 consecutive days (from day 1–10). A treatment schedule is depicted in Figure 16.
A schematic representation of the in vivo study design.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.